Venkatesan Jay

CIK 00014133508 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001413350

Recent Transactions

50 trades

Award
Serina Therapeutics, Inc.$SER
Stock Option (right to buy)
2025-11-07+10,000→ 10,000 total
Award
Elicio Therapeutics, Inc.$ELTX
Stock Option (Right to Buy)
2025-05-19+7,900→ 7,900 total
Award
Serina Therapeutics, Inc.$SER
Series A Convertible Preferred Stock
2025-04-08$5.18/sh+96,525→ 96,525 total
Award
Serina Therapeutics, Inc.$SER
Stock Option (right to buy)
2025-02-12+40,000→ 40,000 total
Exercise of In-Money
Elicio Therapeutics, Inc.$ELTX
Warrant to Purchase Common Stock
2024-11-26−50,000→ 0 total
Exercise of In-Money
Elicio Therapeutics, Inc.$ELTX
Common Stock
2024-11-26$0.01/sh+50,000→ 179,581 total
Award
Elicio Therapeutics, Inc.$ELTX
Stock Option (Right to Buy)
2024-11-21+4,100→ 4,100 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Pre-Funded Warrants
2024-06-28$4.99/sh+50,000→ 50,000 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Common Warrants
2024-06-28+50,000→ 50,000 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Common Warrants
2024-06-28+50,000→ 50,000 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Common Warrants
2024-06-28+50,000→ 50,000 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Pre-Funded Warrants
2024-06-28$4.99/sh+50,000→ 50,000 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Pre-Funded Warrants
2024-06-28$4.99/sh+50,000→ 50,000 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Pre-Funded Warrants
2024-06-28$4.99/sh+50,000→ 50,000 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Pre-Funded Warrants
2024-06-28$4.99/sh+50,000→ 50,000 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Common Warrants
2024-06-28+50,000→ 50,000 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Common Warrants
2024-06-28+50,000→ 50,000 total
Award
Elicio Therapeutics, Inc.$ELTX
Stock Option (right to buy)
2023-12-28+4,100→ 4,100 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2022-07-15$0.45/sh+20,063→ 238,126 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2022-07-15$0.45/sh−20,063→ 70,000 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Common Stock
2022-05-25$1.25/sh+11,313→ 1,891,947 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Common Stock
2022-05-24$1.24/sh+32,200→ 1,721,457 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Common Stock
2022-05-20$1.23/sh+50,000→ 1,689,257 total
Award
Elicio Therapeutics, Inc.$ELTX
Stock Option (Right to Buy)
2022-03-03+160,000→ 760,000 total
Award
Elicio Therapeutics, Inc.$ELTX
Stock Option (Right to Buy)
2022-03-03+600,000→ 600,000 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2022-01-03+10,000→ 10,000 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Common Stock
2021-12-28$2.66/sh+210,337→ 1,639,257 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Common Stock
2021-12-27$2.55/sh+66,907→ 1,428,920 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Common Stock
2021-12-20$2.54/sh+3,527→ 1,362,013 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Common Stock
2021-12-17$2.54/sh+13,742→ 1,358,486 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Common Stock
2021-12-16$2.55/sh+27,883→ 1,344,744 total
Purchase
Elicio Therapeutics, Inc.$ELTX
Common Stock
2021-12-15$2.41/sh+77,604→ 1,316,861 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2021-09-17$9.40/sh−400,000→ 2,600,980 total
Tax Payment
Elicio Therapeutics, Inc.$ELTX
Common Stock
2021-06-24$13.78/sh−41,091→ 1,239,257 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2021-03-31−7,650→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2021-03-31$3.62/sh+7,650→ 218,063 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2021-03-30−7,650→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2021-03-30$4.09/sh+7,650→ 210,413 total
Conversion
Elicio Therapeutics, Inc.$ELTX
Common Stock
2021-02-09$11.57/sh+262→ 1,439,525 total
Sale
Elicio Therapeutics, Inc.$ELTX
Common Stock
2021-02-09$16.00/sh−159,177→ 1,208,086 total
Exercise of In-Money
Elicio Therapeutics, Inc.$ELTX
Common Stock
2021-02-09$6.43/sh+237,152→ 1,439,263 total
Conversion
Elicio Therapeutics, Inc.$ELTX
Common Stock
2021-02-09+165,094→ 1,202,111 total
Exercise of In-Money
Elicio Therapeutics, Inc.$ELTX
Warrant to Purchase Common Stock
2021-02-09−396,329→ 0 total
Tax Payment
Elicio Therapeutics, Inc.$ELTX
Common Stock
2021-02-09$16.00/sh−31,966→ 1,037,017 total
Conversion
Elicio Therapeutics, Inc.$ELTX
Series C Cumulative Convertible Preferred
2021-02-09−1,804→ 0 total
Exercise of In-Money
Elicio Therapeutics, Inc.$ELTX
Warrant to Purchase Common Stock
2021-02-09−237,152→ 0 total
Conversion
Elicio Therapeutics, Inc.$ELTX
Common Stock
2021-02-09$11.57/sh+262→ 1,280,348 total
Conversion
Elicio Therapeutics, Inc.$ELTX
Convertible Promissory Note
2021-02-09→ 0 total
Exercise of In-Money
Elicio Therapeutics, Inc.$ELTX
Common Stock
2021-02-09$6.43/sh+396,329→ 1,598,440 total
Sale
Elicio Therapeutics, Inc.$ELTX
Common Stock
2021-02-09$16.00/sh−159,177→ 1,367,263 total

Companies

Recent Filings

Address

230 CALIFORNIA STREET SUITE 600

SAN FRANCISCO, CA, 94111

View on SEC.gov